Ultrafast liquid chromatography-tandem mass spectrometry determination of donepezil in human plasma: application to a bioequivalence study
Translational and Clinical Pharmacology · 2022 · 30 (1) · 37
DOI: 10.12793/tcp.2022.30.e1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational and Clinical Pharmacology, 2022. Verfasst von Yan-Wen Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Analysis, Key Laboratory of Drug Quality Control and Pharmacovigilance of Ministry of Education, China Pharmaceutical Un…. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: ANSER Medical Technology.
Abstract (Originalsprache)
A liquid chromatography equipped with tandem mass spectrometric method using multi-stage flow rates was developed for the determination of donepezil in human plasma to support a randomized, crossover bioequivalence (BE) study in which healthy volunteers each received a single oral dose of the reference and test formulations of 10 mg donepezil hydrochloride. This integrated liquid chromatography with tandem mass spectrometry (LC-MS/MS) system with electrospray ionization and a deuterium-labeled internal standard (IS) were employed for the positive multiple-reaction-monitoring (MRM) analyses. The baseline separation using a high-resolution monolithic column under gradient and flexible flowrate conditions between donepezil and multiple interfering peaks from the extracted quality control, calibration standard and study plasma samples following simple protein precipitation extraction procedures was accomplished within 1.5 minutes. The ultrafast monolithic column performance in terms of chromatographic separation efficiency, peak asymmetry and resolution and retention time reproducibility was found to be sustainable. The linear dynamic range was detected over a concentration range of 0.2-50 ng/mL. The intra- and inter-day assay accuracy and precision were within 15% for the analyte in individual biological fluids. A positive correlation coefficient (r) greater than 0.995 for donepezil concentrations in study plasma samplers measured by the proposed and the other validated LC-MS/MS methods in support of a bioequivalence study was observed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Analysis, Key Laboratory of Drug Quality Control and Pharmacovigilance of Ministry of Education, China Pharmaceutical University, Nanjing 210009, P. R. China.
- Phase I Clinical Center of Taizhou Hospital, ANSER Medical Technology, Zhejiang 317000, P. R. China.
ORCID-Profile: Yan-Wen Huang, Yunsheng Hsieh
Förderung
- ANSER Medical Technology
Zitieren
APA
Huang, Y. W., Ding, L., Chen, Y. M., Lin, W. C., Lin, F., & Hsieh, Y. (2022). Ultrafast liquid chromatography-tandem mass spectrometry determination of donepezil in human plasma: application to a bioequivalence study. Translational and Clinical Pharmacology, 30(1), 37. https://doi.org/10.12793/tcp.2022.30.e1
Vancouver
Huang YW, Ding L, Chen YM, Lin WC, Lin F, Hsieh Y. Ultrafast liquid chromatography-tandem mass spectrometry determination of donepezil in human plasma: application to a bioequivalence study. Translational and Clinical Pharmacology. 2022;30(1):37. doi:10.12793/tcp.2022.30.e1
BibTeX
@article{Huang2022,
author = {Huang, Yan-Wen and Ding, Li and Chen, Yuan-Ming and Lin, Wei-Chen and Lin, Fei and Hsieh, Yunsheng},
title = {Ultrafast liquid chromatography-tandem mass spectrometry determination of donepezil in human plasma: application to a bioequivalence study},
journal = {Translational and Clinical Pharmacology},
year = {2022},
volume = {30},
number = {1},
pages = {37},
doi = {10.12793/tcp.2022.30.e1}
}
EUVIMED